Valuation: Becton, Dickinson and Company

Market Cap 4.17TCr 3.66TCr 3.37TCr 3.14TCr 5.92TCr 3,96400Cr 6.04TCr 41TCr 16TCr 1,94600Cr 16TCr 15TCr 6,77200Cr P/E 2026 *
37.7x
P/E 2027 * 29.1x
Enterprise Value 5.77TCr 5.06TCr 4.66TCr 4.34TCr 8.19TCr 5,48100Cr 8.35TCr 56TCr 22TCr 2,69000Cr 22TCr 21TCr 9,36400Cr EV / Sales 2026 *
3x
EV / Sales 2027 * 2.83x
Free-Float
74.04%
Yield 2026 *
2.54%
Yield 2027 * 2.59%
1 day+0.56%
1 week+3.15%
Current month+0.72%
1 month+4.88%
3 months-2.51%
6 months-21.81%
Current year-21.46%
1 week 147.2
Extreme 147.2
156.89
1 month 140.11
Extreme 140.11
156.89
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%+3.15%-14.21%-41.81% 4.17TCr
+1.47%+1.70%-32.46%-14.17% 16TCr
+1.03%-1.40%-10.97%-9.33% 10TCr
+1.39%+0.79%-2.92%+50.17% 5.51TCr
-0.17%-2.19%+51.01%+51.71% 5.34TCr
+6.14%+16.23% - - 3.34TCr
+1.57%-2.15%-18.34%-46.27% 2.6TCr
+0.86%+6.39%+62.83%-4.27% 2.54TCr
+1.05%+2.72%-12.30%-2.89% 2.05TCr
-3.47%-1.71%-18.62%-5.46% 2.03TCr
Average +1.03%+2.95%+0.44%-2.48% 5.34TCr
Weighted average by Cap. +1.17%+1.40%-7.54%-1.75%

Financials

2026 *2027 *
Net sales 1.92TCr 1.69TCr 1.55TCr 1.45TCr 2.73TCr 1,82600Cr 2.78TCr 19TCr 7.23TCr 90TCr 7.21TCr 7.06TCr 3,11900Cr 1.97TCr 1.73TCr 1.59TCr 1.48TCr 2.8TCr 1,87400Cr 2.86TCr 19TCr 7.42TCr 92TCr 7.4TCr 7.24TCr 3,20100Cr
Net income 112.46Cr 99Cr 91Cr 85Cr 159.73Cr 11TCr 162.97Cr 1.09TCr 423.55Cr 5.25TCr 422.27Cr 413.13Cr 18TCr 144.92Cr 127.24Cr 117.12Cr 109.14Cr 205.82Cr 14TCr 210.01Cr 1.41TCr 545.79Cr 6.76TCr 544.14Cr 532.37Cr 24TCr
Net Debt 1.6TCr 1.4TCr 1.29TCr 1.2TCr 2.27TCr 1,51700Cr 2.31TCr 16TCr 6.01TCr 74TCr 5.99TCr 5.86TCr 2,59100Cr 1.41TCr 1.24TCr 1.14TCr 1.06TCr 2TCr 1,33800Cr 2.04TCr 14TCr 5.3TCr 66TCr 5.28TCr 5.17TCr 2,28600Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
02/26/02 $152.44 +0.73% 11,18,127
30/26/30 $151.33 -2.49% 21,09,075
29/26/29 $155.19 -0.47% 23,96,596
26/26/26 $155.92 +3.00% 1,21,80,748
25/26/25 $151.38 +2.44% 25,48,949
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
151.33USD
Average target price
177.75USD
Spread / Average Target
+17.46%

Quarterly revenue - Rate of surprise